These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8248084)

  • 21. Glycoxidation: the menace of diabetes and aging.
    Vlassara H; Palace MR
    Mt Sinai J Med; 2003 Sep; 70(4):232-41. PubMed ID: 12968196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
    Dyer DG; Dunn JA; Thorpe SR; Bailie KE; Lyons TJ; McCance DR; Baynes JW
    J Clin Invest; 1993 Jun; 91(6):2463-9. PubMed ID: 8514858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naturally occurring inhibitors against the formation of advanced glycation end-products.
    Peng X; Ma J; Chen F; Wang M
    Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
    Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
    Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physicochemical analysis of structural alteration and advanced glycation end products generation during glycation of H2A histone by 3-deoxyglucosone.
    Ashraf JM; Ahmad S; Rabbani G; Jan AT; Lee EJ; Khan RH; Choi I
    IUBMB Life; 2014 Oct; 66(10):686-93. PubMed ID: 25380060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution".
    Monnier VM; Mustata GT; Biemel KL; Reihl O; Lederer MO; Zhenyu D; Sell DR
    Ann N Y Acad Sci; 2005 Jun; 1043():533-44. PubMed ID: 16037276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of valsartan therapy on protein glycoxidation.
    Monacelli F; Poggi A; Storace D; Durante A; Traverso N; Viviani GL; Odetti P
    Metabolism; 2006 Dec; 55(12):1619-24. PubMed ID: 17142134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
    Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
    Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
    Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
    J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unexpected elevation of pentosidine formation in collagen incubated with glucose by low concentrations of the AGE-inhibitor aminoguanidine.
    Urios P; Grigorova-Borsos AM; Sternberg M
    Diabetologia; 2004 May; 47(5):959-61. PubMed ID: 15170500
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxygen is not required for the browning and crosslinking of protein by pentoses: relevance to Maillard reactions in vivo.
    Litchfield JE; Thorpe SR; Baynes JW
    Int J Biochem Cell Biol; 1999 Nov; 31(11):1297-305. PubMed ID: 10605822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects.
    Odetti P; Fogarty J; Sell DR; Monnier VM
    Diabetes; 1992 Feb; 41(2):153-9. PubMed ID: 1733803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats.
    Waanders F; Greven WL; Baynes JW; Thorpe SR; Kramer AB; Nagai R; Sakata N; van Goor H; Navis G
    Nephrol Dial Transplant; 2005 Oct; 20(10):2060-70. PubMed ID: 15956058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic analysis of furosine and pentosidine in CAPD patients.
    Kumano K; Yokota S; Sakai T; Kobayashi N; Yoshida A; Yoshihara T; Shibata K; Izumi G; Wang H
    Adv Perit Dial; 1997; 13():53-7. PubMed ID: 9360651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia.
    Sell DR; Nagaraj RH; Grandhee SK; Odetti P; Lapolla A; Fogarty J; Monnier VM
    Diabetes Metab Rev; 1991 Dec; 7(4):239-51. PubMed ID: 1813279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid glycation and protein glycation in diabetes and atherosclerosis.
    Miyazawa T; Nakagawa K; Shimasaki S; Nagai R
    Amino Acids; 2012 Apr; 42(4):1163-70. PubMed ID: 20957396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced glycation end-products and the progress of diabetic vascular complications.
    Jakus V; Rietbrock N
    Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes.
    Chellan P; Nagaraj RH
    Arch Biochem Biophys; 1999 Aug; 368(1):98-104. PubMed ID: 10415116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advanced glycation end products: A risk factor for human health].
    Wautier MP; Tessier FJ; Wautier JL
    Ann Pharm Fr; 2014 Nov; 72(6):400-8. PubMed ID: 25438650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.